Latest Axel Ree (ASX:AXL) News

Big moves came from small and mid-cap names tied to drilling, project studies and fresh funding. Healthcare, mining and takeover stocks all had a busy week, but not every strong announcement held its gains.

A handful of small-cap names posted big weekly swings, but the bigger story was a flood of new studies, resource upgrades and funding deals across gold, rare earths and battery materials. Investors chased scale and near-term production, while several raisings and gap-down reopenings showed how quickly early enthusiasm can fade.

Axel REE has confirmed that its Woolrich deposit in Brazil is amenable to in situ recovery (ISR) using a mild magnesium sulphate solution, recovering high-grade rare earths with low impurities. This breakthrough supports the design of field-scale ISR tests planned for late 2026.

Axel REE has appointed Dr Patience Mpofu as Managing Director, positioning the company to advance its rare earths portfolio from exploration into commercial development with planned in-situ recovery trials.

Gold stories drove the week, but the biggest jumps came from drill hits and project studies that gave investors a reason to chase smaller names. At the larger end, merger activity and fresh funding kept attention on producers that want to get bigger, faster.

Axel REE reports thick, shallow rare earth mineralisation with strong heavy rare earth enrichment at Woolrich, underpinning plans for an Indicated resource upgrade and in-situ recovery trials.

Axel REE is accelerating its in situ recovery (ISR) mining trials at the Caladão Project in Brazil, leveraging a low-cost, environmentally friendly extraction method and a unique gallium resource to position itself as a strategic supplier for Western markets.

Small caps drove the biggest moves, with Alvo Minerals surging, Klevo extending a payments-fuelled rally, and FBR jumping on fresh contract news. At the larger end, takeover bids, mine funding deals and a strong Liontown update kept resources and corporate activity at the centre of trading.

Big moves came from deal-driven small caps, critical minerals stories and a fresh burst of funding news across gold, copper and rare earths. The strongest gains came where cash, contracts or takeover terms gave investors something concrete to price in straight away.

Axel REE has selected its Woolrich deposit for inaugural in situ recovery (ISR) field trials, backed by metallurgical breakthroughs doubling gallium extraction and confirming scandium co-recovery, positioning Caladão as a rare dual-pathway rare earth project.

Axel REE Limited has achieved a key operational milestone in its in situ recovery (ISR) development at the Woolrich deposit within the Caladão Project, confirming strong rare earth element leach performance under low-impact magnesium sulphate conditions.

Speculative growth names and biotech drove the biggest gains this week, while one consumer staple copped the heaviest selling after cutting guidance. Deal flow stayed busy, but investors were even more responsive to hard numbers: profit upgrades, feasibility studies, contract wins and fresh drilling results.